Published Paper Details:

In the world, breast cancer is the most frequently diagnosed malignant tumour in women and the leading cause of cancer-related deaths. Around the world, the prevalence of breast cancer is steadily rising. This is why it appears vital to search for novel therapeutic approaches as well as predictive and prognostic indicators, even in the face of advancements in its identification and treatment, which translate into improved mortality rates. Depending on the molecular subtype, different treatment plans apply. Treatment for breast cancer is interdisciplinary and involves systemic therapy as well as locoregional therapy (surgery and radiation therapy). Chemotherapy, antiHER2 therapy for HER2positive disease, hormone therapy for hormone-positive disease, and, more recently, immunotherapy are examples of systemic therapies. More than 15% to 20% of all cases of breast cancer are triple negative. Because of its high invasiveness and poor responsiveness to treatment, it poses a therapeutic challenge and is hence of great study interest. Anticipated treatment approaches for breast cancer seek to tailor care to each patient and adjust the dosage and intensity of care according to the cancer's biology and early response to treatment. The article gives an overview of the literature on breast carcinoma--a disease impacting women across the world.